Happiest Minds invests Rs. 1 crore to establish advanced molecular test lab and 3 ICU ventilator beds within SJICR

India Pharma Outlook Team | Friday, 14 October 2022

 India Pharma Outlook Team

Happiest Minds Technologies is opening a molecular testing laboratory at the Sri Jayadeva Institute of Cardiovascular Sciences and Research (SJICR) in Bengaluru. The company has contributed Rs. 1 crore to the Institute for establishing the testing lab and 3 ICU ventilator beds. The laboratory with its state-of-the-art research facilities and infrastructure was unveiled by Dr. Ravi V, Senior Professor and HOD, Department of Neurovirology from NIMHANS in the presence of Dr C N Manjunath, senior cardiologist and director, Sri Jayadeva Institute and Venkatraman Narayanan, MD & CFO, Happiest Minds. Venkatraman Narayanan, MD & CFO, Happiest Minds Technologies said, “Social Responsibility is a core value of Happiest Minds.

In line with our 5-year vision of being a responsible corporate citizen and a leader in social responsibility initiatives, this facility further adds to our ongoing efforts to expand medical facilities for the public and undertake innovative R&D and collaboration for understanding human health and disease.” Aligned with the company’s CSR objectives for community engagement and contribution of resources for social and environmental causes, the Company has associated with several other partners like the Akshaya Patra Foundation, Bengaluru West Lions Super Specialty Eye Hospital and NGOs like Baale Mane, Balajothi Centre for the Disabled, One Billion Literates Foundation & Jeevarathni Foundation.

© 2025 India Pharma Outlook. All Rights Reserved.